Trial Profile
A Multicenter, Multinational, Randomized, Open-Label, Parallel-Group Trial to Evaluate the Safety of Fentanyl TAIFUN Treatment after Titrated Dose Administration and the Current Breakthrough Pain Treatment for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy.
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 22 Sep 2022
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary) ; Fentanyl
- Indications Cancer pain
- Focus Adverse reactions
- Acronyms FIND-S
- Sponsors Akela Pharma
- 22 Sep 2022 This trial is Completed at Finland location, According to European Clinical Trials Database record.
- 13 Jan 2009 Integrated information from ClinicalTrials.gov record.
- 14 Jul 2008 New trial record.